Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Valiltramiprosate by Alzheon for Down Syndrome: Likelihood of Approval
Valiltramiprosate is under clinical development by Alzheon and currently in Phase II for Down Syndrome. According to GlobalData, Phase II...
Data Insights
Valiltramiprosate by Alzheon for Unspecified Central Nervous System Disorders: Likelihood of Approval
Valiltramiprosate is under clinical development by Alzheon and currently in Phase II for Unspecified Central Nervous System Disorders. According to...